Wells Fargo & Company »

Nkgen Biotech shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $90 48 1.90
2023-12-31 $129 47 2.74

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech